Genzyme

CABLIVI

Manufacturer:

Genzyme

Cablivi HCPCS:

C9047

HCPCS Code Descriptor:

Injection, caplacizumab-yhdp, 1 mg

Category:

C Code

Cablivi NDCs:

58468-0225-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cablivi:

CABLIVI is a Hematology drug manufactured by Genzyme and administered via the Intravenous route of administration. The C Code: C9047 is aligned to the drug CABLIVI.

ACCESS PRICING AND MORE BY REGISTERING

C9047 Added Date:

July 1, 2019

C9047 Effective Date:

July 1, 2019

C9047 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cablivi billing and coding information.
Cablivi patient assistance information can be found through The CABLIVI Patient Solutions Copay Assistance Program at the URL: https://www.cablivi.com/
CABLIVI prescribing information can be found at the link below:
Information regarding CABLIVI’s side effects can be found at MedlinePlus